Issue and repurchase of series C shares for share saving program
Pursuant to the authorization granted by the annual general meeting on 14 November 2019, the board of directors of Ascelia Pharma AB (”Ascelia”) has resolved to issue and immediately thereafter repurchase 510,545 series C shares. The shares are issued and repurchased in accordance with the share saving program LTI 2019, which was adopted by the annual general meeting on 14 November 2019.Pursuant to the authorization granted by the annual general meeting on 14 November 2019, the board of directors of Ascelia has resolved on a directed issue of 510,545 series C shares to Svenska